Novartis, BeiGene's PD-1 hits goal in first-line liver cancer. Should Roche worry about Tecentriq?
9th August 2022 Uncategorised 0 Novartis, BeiGene’s PD-1 hits goal in first-line liver cancer. Should Roche worry about Tecentriq?
aliu
Tue, 08/09/2022 – 11:05
More: Novartis, BeiGene's PD-1 hits goal in first-line liver cancer. Should Roche worry about Tecentriq?
Source: fierce